Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance

BMJ ◽  
2014 ◽  
Vol 349 (jul17 12) ◽  
pp. g4356-g4356 ◽  
Author(s):  
S. Rabar ◽  
M. Harker ◽  
N. O'Flynn ◽  
A. S. Wierzbicki ◽  
Keyword(s):  
Cardiovascular Disease ◽  
Risk Assessment ◽  
Cardiovascular Risk ◽  
Secondary Prevention ◽  
Lipid Modification ◽  
Primary And Secondary Prevention ◽  
Cardiovascular Risk Assessment ◽  
Nice Guidance ◽  
Prevention Of Cardiovascular Disease

Cost offset of lipid-lowering drugs for primary and secondary prevention of cardiovascular disease

2005 ◽  
Vol 5 (2) ◽  
pp. 193-205 ◽  
Author(s):  
Luca Degli Esposti ◽  
Mirko Di Martino ◽  
Stefania Saragoni ◽  
Alessandro Capone ◽  
Pierluigi Russo ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Secondary Prevention ◽  
Lipid Lowering ◽  
Primary And Secondary Prevention ◽  
Lipid Lowering Drugs ◽  
Cost Offset ◽  
Prevention Of Cardiovascular Disease
Sign in / Sign up

Export Citation Format

Share Document